Nonfluoroscopic catheter ablation in patients with atrial fibrillation
https://doi.org/10.15829/1560-4071-2020-3928
Abstract
The article demonstrates available literature data on the nonfluoroscopic catheter ablation of atrial fibrillation (AF). The main disadvantages of standard fluoroscopic catheter ablation are shown. The research results on the use of intracardiac echocardiography are presented. The first experience of using the fluoroscopy-free procedure in Russia as a pilot study is also presented. During the period from December 2017 to December 2019, 28 radiofrequency ablations and 40 pulmonary vein cryoballoon ablations were performed without fluoroscopy using threedimensional imaging and intracardiac echocardiography. Despite the small number of large studies in this area, clinical cases described in the literature, as well as their own results, demonstrate the safety of using three-dimensional imaging in combination with intracardiac echocardiography as an alternative to fluoroscopy. Application of the approach is of undoubted practical interest and requires further study in large studies.
About the Authors
O. V. SapelnikovRussian Federation
Moscow
Competing Interests: not
D. F. Ardus
Russian Federation
Moscow
Competing Interests: not
V. S. Kostin
Russian Federation
Moscow
Competing Interests: not
T. M. Uskach
Russian Federation
Moscow
Competing Interests: not
D. I. Cherkashin
Russian Federation
Moscow
Competing Interests: not
I. R. Grishin
Russian Federation
Moscow
Competing Interests: not
K. B. Bogatyreva
Russian Federation
Moscow
Competing Interests: not
A. V. Emelyanov
Russian Federation
Moscow
Competing Interests: not
A. A. Kulikov
Russian Federation
Moscow
Competing Interests: not
O. A. Nikolaeva
Russian Federation
Moscow
Competing Interests: not
R. S. Akchurin
Russian Federation
Moscow
Competing Interests: not
References
1. Calkins H, Reynolds MR, Spector P, et al. Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation. Two Systematic Literature Reviews and MetaAnalyses. Circulation: Arrhythmia and Electrophysiology. 2009;2(4):349-61. doi:10.1161/CIRCEP.108.824789.
2. Hunter RJ, Berriman TJ, Diab I, et al. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circulation: Arrhythmia and Electrophysiology. 2014;7(1):31-8. doi:10.1161/CIRCEP.113.000806.
3. Di Biase L, Mohanty P, Mohanty S, et al. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients with Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial. Circulation. 2016;133(17):1637-44. doi:10.1161/CIRCULATIONAHA.115.019406.
4. Marrouche NF, Brachmann J, Andresen D, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378:417-27. doi:10.1056/NEJMoa1707855.
5. Packer DL, Mark DB, Robb RA, et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized ClinicalTrial. JAMA. 2019;321(13):1261-74. doi:10.1001/jama.2019.0693.
6. Packer DL, Kowal RC, Wheelan KR, et al. Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial Fibrillation: First Results of the North American Arctic Front (STOP AF) Pivotal Trial. J Am Coll Cardiol. 2013;61(16):1713-23. doi:10.1016/j.jacc.2012.11.064.
7. Kuck KH, Brugada J, Furnkranz A, et al. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med. 2016;374:2235-45. doi:10.1056/NEJMoa1602014.
8. Houmsse M, Daoud EG. Radiation exposure: a silent complication of catheter ablation procedures. Heart Rhythm. 2012;9(5):715-6. doi:10.1016/j.hrthm.2012.01.015.
9. Heidbuchel H, Wittkampf FH, Van E, et al. Practical ways to reduce radiation dose for patients and staff during device implantations and electrophysiological procedures. Europace. 2014;16(7):946-64. doi:10.1093/europace/eut409.
10. De Ponti R. Reduction of radiation exposure in catheter ablation of atrial fibrillation: Lesson learned. World J Cardiol. 2015;7(8):442-8. doi:10.4330/wjc.v7.i8.442.
11. Miller DL, Klein LW, Balter S, et al. Special communication — occupational health hazards in the interventional laboratory: progress report of the multispecialty occupational health group. J Am Coll Radiol. 2010;7(9):679-83. doi:10.1016/j.jacr.2010.07.010.
12. Ferguson JD, Helms A, Mangrum JM, et al. Catheter ablation of atrial fibrillation without fluoroscopy using intracardiac echocardiography and electroanatomic mapping. Circulation: Arrhythmia and Electrophysiology. 2009;2(6):611-9. doi:10.1161/CIRCEP.109.872093.
13. Reddy VY, Morales G, Ahmed H, et al. Catheter ablation of atrial fibrillation without the use of fluoroscopy. Heart Rhythm. 2010;7(11):1644-53. doi:10.1016/j.hrthm.2010.07.011.
14. Da Costa A, Ben H’dech M, Romeyer-Bouchard C, et al. Remote-controlled magnetic pulmonary vein isolation using a new three-dimensional non-fluoroscopic navigation system: A single-centre prospective study. Archives of Cardiovascular Diseases. 2013;106(8-9):423-32. doi:10.1016/j.acvd.2013.04.008.
15. Percell RL, Sharpe E, Percell JE. SANS FLUORO (SAy No Series to FLUOROscopy): A First-Year Experience. Journal of the American College of Cardiology. 2016;7(11):2529-2534. doi:10.19102/icrm.2016.071102.
16. Sommer P, Bertagnolli L, Kircher S, et al. Safety profile of near-zero fluoroscopy atrial fibrillation ablation with non-fluoroscopic catheter visualization: experience from 1000 consecutive procedures. EP Europace. 2018;20(12):1952-8. doi:10.1093/europace/eux378.
17. Cacciotti L, Passaseo I. Management of Atrial Fibrillation in Pregnancy. J Atr Fibrillation. 2010;3(3):295. doi:10.4022/jafib.295.
18. European Society of Gynecology (ESG); Association for European Paediatric Cardiology (AEPC); German Society for Gender Medicine (DGesGM); Regitz-Zagrosek V. et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:3147-97. doi:10.1093/eurheartj/ehr218.
19. Bongiorni MG, Di Cori A, Soldati E, et al. Radiofrequency catheter ablation of atrioventricular nodal reciprocating tachycardia using intracardiac echocardiography in pregnancy. Europace. 2008;10(8):1018-21. doi:10.1093/europace/eun120.
20. Szumowski L, Szufladowicz E, Orczykowski M, et al. Ablation of severe drug-resistant tachyarrhythmia during pregnancy. J Cardiovasc Electrophysiol. 2010;21(8):877-82. doi:10.1111/j.1540-8167.2010.01727.
21. Chen G, Sun G, Xu R, et al. Zero-fluoroscopy catheter ablation of severe drug-resistant arrhythmia guided by Ensite NavX system during pregnancy. Two case reports and literature review. Medicine (Baltimore). 2016;95(32):e4487. doi:10.1097/MD.0000000000004487.
22. Kozluk E, Piatkowska A, Kiliszek M, et al. Catheter ablation of cardiac arrhythmias in pregnancy without fluoroscopy: A case control retrospective study. Adv Clin Exp Med. 2017;26(1):129-34. doi:10.17219/acem/68275.
23. Sapelnikov OV, Partigulova AS, Saidova MA, et al. The role of intracardiac echocardiography in clinical electrophysiology. Cardiology. 2015;1:64-9. (In Russ.)
Supplementary files
Review
For citations:
Sapelnikov O.V., Ardus D.F., Kostin V.S., Uskach T.M., Cherkashin D.I., Grishin I.R., Bogatyreva K.B., Emelyanov A.V., Kulikov A.A., Nikolaeva O.A., Akchurin R.S. Nonfluoroscopic catheter ablation in patients with atrial fibrillation. Russian Journal of Cardiology. 2020;25(12):3928. (In Russ.) https://doi.org/10.15829/1560-4071-2020-3928